Moreover, we examined interstitial fibrosis, another hypertrophic pathological phenotype, and found PARP16 deficiency notably dampened interstitial fibrosis in TAC-induced experimental cardiac hypertrophy model by Masson and Sirius Red Staining of heart sections (Fig. 5i, j). Here, PARP16 is linked to cardiac hypertrophy.